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Abstract 
 
This dissertation examines the accounting treatment of research and development by 
Irish listed companies. Research and development has become an increasing element 
within an organisations development both on a competitive and an economic level. 
Due to the importance that now surrounds research and development, the accounting 
treatment adopted by companies has become a very important topic. This dissertation 
is designed at examining the current accounting treatment followed by Irish listed 
companies. 
 
The research for this dissertation is split into primary and secondary research. The 
secondary research is broken down into analysing the literature and the financial 
statements of Irish listed companies. The literature offers a comprehensive overview 
of the accounting treatment of research and development which is relevant to Ireland, 
the UK and the US. The literature review also outlines the importance of the valuation 
of research and development and the tax credit that is available for companies that 
undertake research and development. The financial statements were analysed to 
determine how these companies accounted for research and development and how 
much was spent. 
 
The primary research included questionnaires to Irish listed companies and two semi-
structured interviews. Both these addressed the issues that the researcher found in 
conducting the secondary research namely, accounting for research and development, 
the valuation of research and development, the tax credit for research and 
development and what Ireland’s location is like as a research and development 
economy. 
 
The primary research revealed that Irish listed companies must abide by the 
international accounting standards and therefore if development expenditure meets the 
criteria then it must be capitalized with all research expenditure being expensed to the 
statement of comprehensive income. The research identified that the most common 
method for valuation was the cost model and that the tax credit is a significant 
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influence on research and development. Finally the primary research revealed that 
Ireland is regarded as a good place to conduct research and development.  
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Chapter 1 – Introduction 
 
1.1 Introduction 
 
The purpose of this chapter is to provide an overview of the research project. This 
chapter will include the background to the project, reasons for the research topic being 
investigated, the research question and objectives and an overview of the structure of 
the research project. 
 
1.2 Background 
 
Ireland, the UK and the US all have their own accounting standards. The International 
Accounting Standards (IAS) and the Financial Reporting Standards (FRS) are used in 
Ireland and the UK with the US Generally Accepted Accounting Principles (GAAP) 
applicable to the US, but so far no one set of accounting standards is accepted 
globally. There have been talks between the International Accounting Standards 
Board (IASB) and the Financial Accounting Standards Board (FASB) about a 
convergence between these accounting standards in order to make financial reports 
more comparable with those of other companies. However, this has not been achieved 
so far because of disagreements over certain standards. One of the standards that there 
is disparity in is intangible assets.   
 
There has been a lot of controversy regarding intangible assets, not just their 
accounting treatment but also issues regarding their definitions and classification.  
While there are many forms of intangible assets, this paper is going to focus mainly 
on research and development (R&D), which has become more important in recent 
years. For centuries R&D has been the back bone for many items; however some of 
these items are too simple nowadays to be regarded as R&D like the creation of the 
sandwich which was named after the Earl of Sandwich.  It is argued that this great 
invention in the 1700’s would not be classed as R&D today based on the strict 
definitions of R&D now in place (O’Connor and Forde, 2004). 
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Research (Aghion and Howitt, 1992; Ding, 2007) has shown that there is a linkage 
between R&D and economic growth, future income and productivity improvements. 
This simply means that a company’s level of output will increase when the level of 
R&D input is increases. Economic growth is an important aspect for companies in 
general and for them to be seen as having competitive advantage. Therefore, if there a 
strong correlation between economic growth and R&D, then R&D must also be 
significant to companies (Griffith, 2000).  
 
1.3 Research Topic and Question 
 
The research topic being investigated is an exploration into how R&D is treated in 
Ireland, focusing on listed companies. This research topic gives rise to the following 
research question: 
“How Research and Development is accounted for Ireland by companies listed on the 
Irish Stock Exchange (ISEX)?” 
 
1.4 Research Objectives 
 
• To compare and contrast how R&D is accounted for in Ireland, the UK and 
the US and the impact of future convergence by global standard setters.  
 
This will help distinguish the accounting treatment between the three countries 
and to see where the problem arises that interferes with the harmonization of 
accounting standards dealing with this area. 
 
• To examine how the valuation of R&D is important.  
 
There are many valuation methods available; however not all are compatible with 
R&D. This objective will look at which is the most relevant method used for R&D 
as prescribed by the standards as this is thought to be linked to share price 
movements.  
 
• To establish what influence the R&D tax credit has on companies.  
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The R&D tax credit has become popular in recent years; this will look to see if its 
availability has in fact any impact on companies undertaking R&D. 
 
• To determine what Ireland is like as a R&D economy. 
 
Around the world, most countries are becoming more R&D based and focused. 
This objective is aimed at determining whether Ireland is regarded as being 
suitable place for carrying out R&D and what the factors are in determining this? 
 
1.5 Reasons for the research topic 
 
The main merits for conducting research on this subject matter is that R&D is a very 
topical issue, especially in the current economic climate, as a creative edge is needed 
for both new and improving product/services to get the economy out of the poor 
situation it finds itself in. Companies are trying to cut costs in order to survive but at 
the same time they must maintain strong innovation to remain competitive. Therefore 
there may be a trade off required as R&D expenses are normally one of the largest 
expenses of a company. It is clear that R&D is an area of importance therefore the 
researcher believes that this quantifies further investigation.  
 
The main people that this research will be of benefit to include the following: 
• Academics – there has been a lot of studies conducted on both intangible 
assets and R&D, however these are mostly related to countries outside Ireland. 
This research project will consider Irish listed companies which will give 
academics an Irish perspective of R&D.  
• Companies – many companies spend large amounts of resources in the hope of 
creating new products, and/or improving or introducing applications for 
existing products in order to stay competitive and ultimately increase profits.  
However some companies are unaware that they are conducting R&D and do 
not reap the benefits that can be obtained such as tax incentives. Therefore this 
research will be useful to companies so that they are able to get a more in 
depth insight into R&D which could save them money.   
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• Students – as R&D is dealt with in accounting standards, it will be part of the 
curriculum for students. This dissertation will give students a greater 
understanding of how the accounting treatment for R&D is applied in practice 
by listed companies. 
 
1.6 Limitations of Research 
 
There are limitations as to the effectiveness of the research as implemented by the 
author, mainly cost and access to information, with the most prevalent limitation 
being time. The researcher realistically had just less than three months to conduct 
their primary research which impacted on the number of responses especially in 
relation to questionnaires that were returned. However, the questionnaires were sent 
with a stamped addressed envelope for the ease of return with no expense being 
incurred by the respondents of the questionnaires.  
 
As stated earlier there is also a problem that the respondents may interpret the 
questions incorrectly which would result in the findings not being accurate. Although 
the questionnaires where addressed to the Chief Financial Officer (CFO) of listed 
companies it cannot be guaranteed that the questionnaires were completed by them 
which could impact on the overall research if incorrect information was given. 
 
The limitations regarding the interviews that were conducted is interviewer bias, 
however with a theme sheet to follow this bias should be reduced considerably. 
 
The gathering of secondary research literature was limited to what could be accessed 
from databases, journals, books and internet sites as other facilities were not available 
in rural Ireland, without major expense on the researcher, as most of literature was 
conducted outside Ireland. 
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1.7 Organisation of Dissertation 
 
Chapter 1 – Introduction 
The purpose of this chapter is to provide an overview of the background to the 
research project, the research question and objectives used to answer the research 
questions and achieve the research aims.  
 
Chapter 2 – Literature Review 
This chapter outlines the relevant literature in the research area and is critically 
reviewed by the author. It looks at literature in the areas of the accounting treatment 
of R&D, valuation and the R&D tax credit. 
 
Chapter 3 – Research Methodology 
This chapter outlines the methodology developed and used by the author to answer 
the research question and achieve the research aims. 
 
Chapter 4 – Data Analysis and Findings 
This chapter presents the findings that were achieved using the methodology that was 
developed in chapter 3. These findings are analysed, summarised and then discussed. 
 
Chapter 5 – Conclusions and Recommendations 
This chapter summarises the findings from the research and their relevance to the 
research topic. It will include conclusions that will hopefully provide answers to the 
research question and achieve the research objectives. 
 
1.8 Conclusion 
 
This chapter presents an overview of the research dissertation. It includes the 
background of the research subject which has shaped the research question and 
objectives. The chapter also includes an overview of the reasons for the research topic 
which includes merit and justification. Finally this chapter contains the limitations of 
this research and an overview of how the dissertation will be structured. 
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Chapter 2 – Literature Review 
 
2.1 Introduction 
 
This chapter will provide the reader with a summary of the literature that is relevant to 
the authors’ research topic. The researcher will include literature that outlines the 
accounting treatment of R&D, the valuation of R&D and the R&D tax credit. 
 
2.2 Key Definitions 
 
Below are definitions that are relevant to this research. This helps the reader to 
understand some of the phrases used within this dissertation. 
 
2.2.1 Intangible Assets 
 
Intangible assets are defined by the IASB as “an identifiable non monetary asset 
without physical substance” (IAS 38). Therefore the problem that some people have is 
that if it is not physical, how it can be classed as an asset?   
 
Lev and Zarowin (1999); Stolowy and Jeny-Cazavan (2001) claim that intangible 
assets should be treated like tangible assets. Likewise, Hendriksen and van Breda 
(1992) argue that intangibles are no less assets just because they lack substance. Their 
recognition should follow, therefore, the same rules as all assets. Intangible assets can 
be generated internally, as part of business combinations, by government grants or by 
external purchases. 
 
2.2.2 R&D 
 
According to the Central Statistics Office (CSO), R&D is creative work undertaken 
on a systematic basis in order to create new or improved products, processes services 
or other applications.  R&D is distinguishable from other activities by the presence of 
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an appreciable element of novelty and by the resolution of problems and uncertainties 
using scientific or technological means (CSO, 2008).  
 
However, most accounting standards like to distinguish between the research and 
development phases separately in order to prescribe the correct accounting treatment. 
2.2.2.1 Research 
Research has been defined as an original or planned investigation undertaken with the 
hope of gaining new scientific or technical knowledge and understanding (Connelly, 
2009). 
Examples of research include:  
• Activities aimed at obtaining new knowledge; 
• The search for alternatives for materials, devices, products, processes, systems 
and services; 
• The formulation, design, evaluation and final selection of possible alternatives 
for new or improved materials, devices, products, processes, systems and 
services (Elliott & Elliott, 2009). 
 
2.2.2.2 Development 
Statement of Standard Accounting Practice (SSAP) 13 has defined development as 
“the use of scientific or technical knowledge in order to produce new and 
substantially improved materials, devices, products or services, to install new 
processes or systems prior to the commencement of commercial productions or 
commercial application, or to improve substantially those already produced or 
installed” (Black, 2003 (Pg: 73)). 
 
The following are examples of development: 
• Design, construction and testing of pre-production prototypes and models and 
development batches; 
• Design of products, services, processes or systems involving new technology 
or substantially improving those already produced or installed; 
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• Construction and operations of pilot plants that is not feasible for commercial 
production (Elliott & Elliott, 2009). 
2.2.3 Amortization 
 
Amortization is the equivalent of depreciation but for intangible assets. This means 
that the intangible assets must be reduced in order to reflect age or obsolescence as 
most assets lose value over time.  The rate at which this is applied is at the discretion 
of individual companies (Elliott & Elliott, 2004).  
 
However, this only applies to intangible assets with finite lives (a limited time 
period). For intangible assets with infinite lives (no foreseeable time limit to the 
period over which the asset is expected to generate cash) these should not be 
amortized. 
 
2.2.4 Impairment 
 
Impairment occurs when an assets carrying amount (cost less any accumulated 
depreciation) exceeds its recoverable amount (the higher of the amount that the asset 
can be sold for or its value in use).  When this happens the excess is expensed to the 
statement of comprehensive income (formerly the income statement) and thus reduces 
the asset to the recoverable amount (Wood, 2005). 
 
2.2.5 Capitalization 
 
Capitalization is an accounting method used to delay the recognition of expenses by 
recording the expense as an asset. In general, capitalizing expenses is beneficial as 
companies acquiring new assets can spread out the cost over a period of time via 
amortization, without an immediate negative affect on profit. 
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2.3 Accounting treatment of R&D 
 
2.3.1 Harmonization of Accounting Standards 
 
Although accounting standards are important determinants of the quality of financial 
reporting, they differ across countries. It is believed that such differences reduce the 
value and the relevance of accounting information but if all companies followed the 
same set of accounting standards, external financial reports would provide more 
standardized disclosures and more useful accounting information (Ding et al, 2007). 
In recent years, there have been talks such as the Norwalk Agreement to harmonize or 
converge accounting standards across countries, i.e. to adopt a universal set of 
accounting standards, following corporate collapses such as Enron and WorldCom 
(FASB, 2002).   
 
The Norwalk Agreement signed in 2002 by the FASB and the IASB was established 
to set global accounting standards. However, this convergence process has had its 
problems. It was intended that this agreement would be implemented by 2005, but 
five years later the convergence process still has not been fully implemented due to 
disharmony over certain areas of accounting (O’Kelly, 2009). Accounting for R&D is 
one of the areas of divergence between the two accountancy boards. And, although 
R&D is becoming central to the competitive advantage of more companies, the FASB 
and the IASB each prescribe different treatments for R&D (Nixon, 1997).  
 
We will now look at the different accounting standards that are applicable to R&D 
within Ireland, the UK and the US. 
 
2.3.2 Statement of Standard Accounting Practice (SSAP) 13 
 
SSAP 13 is the accounting standard for R&D under Irish and UK GAAP. This 
standard allows a certain amount of choice to companies regarding the treatment of 
costs incurred by projects in relation to R&D. 
LITERATURE REVIEW 
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SSAP 13 was issued in December 1977 and revised in January 1989. The main 
elements of the standard refer to the following: 
• That the cost of the asset (bought or constructed) to provide R&D facilities is 
capitalized and written off over its useful life. 
• All expenditure incurred on research should be written off within the period. 
• Any development expenditure should be written off in the period or if it meets 
the following criteria, it may be capitalized (at the managers’ discretion): 
 There is a clearly defined project; 
 The related expenditure is separately identifiable; 
 The outcome of the project has been assessed with reasonable 
certainty as to technical feasibility and commercial viability; 
 The aggregate development  costs are expected to be exceeded by 
future sales and revenue; 
 There are adequate resources to enable the project to be completed 
and to provide any consequential increases in the working capital 
(SSAP 13). 
 
Under SSAP 13 if a company wishes to capitalize development costs, it must first be 
amortized, then over the products sale period or useful life and an annual review 
should take place to determine if the development costs still meet the criteria to 
capitalize. Also an impairment review is required to determine if the value of the 
development costs needs to be written down to its recoverable amount. 
 
The disclosure requirements under SSAP 13 include: 
• The accounting policy that is followed should be clearly stated; 
• The total amount of R&D expenditure charged to the statement of 
comprehensive income; 
• A split between research and development components; and 
• Any amortization of development expenditure (Black, 2003). 
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2.3.3 IAS 38 
 
IAS 38 is the accounting standard for intangible assets. This research will only be 
looking at the accounting treatment for R&D within IAS 38. All European Union 
(EU) companies listed on a stock exchange must abide by the IAS’s; however, 
compliance by non-listed companies in Ireland and the UK is voluntary.   
 
The accounting treatment for R&D differs depending on whether the expenditure 
relates to research expenditure or development expenditure. Research expenditure 
must always be charged to the statement of comprehensive income unless externally 
acquired which results in capitalization. Like research expenditure, development 
expenditure can also be capitalized on external purchase whereas internally generated 
development expenditure must be capitalized provided a strict set of criteria is met. 
These include: 
• Completing the intangible asset (with adequate financial, technical and other 
resources available) so the intangible asset will be available for use or resale; 
• That the intangible asset will generate probable future economic benefits; and 
• That the company has the ability to measure reliably the expenditure 
attributable to the intangible asset during its development phase (Connelly, 
2009 and Elliott & Elliott, 2009). 
 
Although not directly attributable under IAS 38, the capitalization of assets (bought or 
constructed) to provide R&D facilities is dealt with under IAS 16 Property, Plant and 
Equipment (PPE). This standard stated that depreciation of PPE used for development 
activities may be included in the cost of an intangible asset recognized in accordance 
with IAS 38 Intangible Assets (IAS 16, paragraph 49). 
 
If a company cannot split expenditure into research or development then the entire 
expenditure must be written off to the statement of comprehensive income. 
 
Any R&D projects acquired in a business combination are recognised as an asset at 
cost, even if a component is research (i.e. it is capitalized). However, any future costs 
relating to the project will be dealt with like any other R&D expenditure, for example 
LITERATURE REVIEW 
 12 
if the future costs relate to research it will not be capitalized but if is solely 
development (and meets the criteria) then it must be capitalized as stated by 
International Financial Reporting Standards (IFRS) 3 Business Combinations. 
 
IAS 38 requires the following disclosures for R&D: 
• Useful life/amortization rate; 
• Gross carrying amount and accumulative amortization; 
• Reconciliation of the carrying amount at the beginning of the period and the 
end of the period showing any additions, disposals, impairments, revaluations, 
amortization and any foreign exchange differences; 
• Basis for determining if the R&D has an indefinite life; 
• If any government grants were received in relation to R&D; and 
• The total amount charged to the statement of comprehensive income in 
relation to R&D expenditure in the current accounting period (IASB, 2009). 
 
2.3.4 Statement of Financial Accounting Standards (SFAS) 2 
 
SFAS 2 “Accounting for R&D Costs” is the accounting standard applied under US 
GAAP for all US companies. It has been in effect since 1974.  
 
This statement requires that all R&D costs be charged as an expense to the statement 
of comprehensive income when incurred. These costs include: 
• Costs of materials, equipment and facilities that have no alternative future 
uses; 
• Salaries, wages and other related costs of personnel engaged in R&D 
activities; 
• Purchased intangible assets that have no alternative future uses; 
• Contract services; and 
• A reasonable allocation of indirect costs, except for general and administrative 
costs (Gornik-Tomaszewski and Millan, 2005). 
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SFAS 2 has dismissed the capitalization of R&D expenditure due to the uncertainty of 
future benefits of R&D projects and also because of the lack of a fundamental 
relationship between expenditure and benefits (SFAS 2). As capitalization of R&D is 
not permitted under US GAAP, any asset (bought of constructed) to provide R&D 
facilities cannot be capitalized, unlike SSAP 13 and IAS 38. 
 
Any R&D acquired as part of a Business Combination in the US must be regarded as 
an expense as soon as it is acquired (Gornik-Tomaszewski and Millan, 2005). 
 
SFAS 2 requires that a company discloses, in its financial statements, the amount of 
R&D that it charges to expense for each accounting period (SFAS 2).  
 
2.4 Capitalization of R&D 
 
The capitalization of R&D costs is a controversial accounting issue because of the 
argument that such capitalization is motivated by incentives to manipulate earnings 
(Markarian et al, 2008). This manipulation of earnings occurs by capitalizing the 
R&D expenditure instead of expensing this through the statement of comprehensive 
income, thus increasing overall earnings. This also enhances the asset valuation of the 
companies.  
 
However, an additional danger of the capitalization of R&D is that future economic 
benefits are estimated and therefore can be wrong. Such was the case with Rolls 
Royce Ltd in the early 1970’s where substantial R&D expenditure on a new aero 
engine was capitalized but the estimated future economic benefits failed to materialise 
(Black, 2003). This resulted in the company writing off the accumulated expenditure 
that was capitalized thus leaving a major accounting loss for that period. This loss 
would not have been as extensive in that period if it was not capitalized over the total 
length of the R&D phase. This resulted in the entire expenditure being written off 
when the future economic benefits became vague.  
 
As per IAS 38 and SSAP 13, it is only development costs that can be capitalized with 
the exception of research which is acquired within a business combination. SFAS 2 
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does not permit the capitalization of either research or development even when 
externally generated, i.e. through business combinations. Although the accounting 
standards in the US does not allow for capitalization it is also faced with this 
controversial accounting issue as it must justify why capitalization is prohibited. It 
may well be that capitalization could lead to manipulation of financial statements; that 
future economic benefits are uncertain; or for other reasons which could lead to 
corporate scandals. 
 
It remains unclear if capitalizing R&D has a positive or negative effect on the market 
value of companies’ shares. Hirschey and Weygandt (1985), Sougiannis (1994) and 
Smith et al. (2001), have found a strong positive correlation between financial 
statement information and the market value of equity when R&D is capitalized 
compared to notional expensing. However, other studies have shown that capitalized 
R&D is negatively associated with stock prices and returns. This negative coefficient 
on capitalized R&D implies that investors are concerned with and react negatively to 
capitalization of R&D (Cazavan-Jeny and Jeanjean, 2006, and Kallunki et al, 2009). 
 
2.4.1 Valuation of R&D 
 
The valuation of assets is one of the contemporary issues in accounting. The valuation 
of R&D is extremely important especially if a company capitalizes the development 
expenditure, as an appropriate valuation must be placed on these assets so that it truly 
reflect its value to the company. As companies are now becoming more knowledge-
based, “intangible assets will comprise an increasing percentage of the value of 
businesses acquired”, (Quilligan, 2006 (Pg: 10)). However, choosing the correct 
valuation method is problematic as numerous options are available, for example: cost 
and fair value which also leads to the choice of amortization and/or impairment. 
 
Two of the main challenges with intangible asset valuations are the appropriate 
valuation methodology and selecting the appropriate economic life for each asset. The 
correct valuation method is determined according to the type of the asset and the 
industry; however each method has its own advantages and disadvantages. Briefly the 
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three valuation methods that are relevant to intangible assets according to Quilligan 
(2006) are: 
1. Market Method – this provides the best evidence of fair value because it relies 
on evidence from actual markets. However, for companies this method may be 
inappropriate as finding companies carrying out similar R&D activities may 
be difficult. Also as mentioned above it is unknown whether capitalization of 
R&D has any impact on markets; therefore this method may be irrelevant to 
placing a value on R&D.  
2. Income Method – this method is based on future economic benefits from 
owning the asset, the difficulty here is that the company may not have 
ownership of the asset. Another difficulty that has been stated throughout this 
literature review is that future economic benefits cannot be easily determined. 
As IAS 38 requires that development expenditure must have a future 
economic benefit before it is capitalized, this method may be suitable for 
placing a value on R&D. 
3. Cost Method – this assesses the cost of the asset but this does not take into 
account present value therefore unless replacement cost (valuing the assets at 
what they would cost today) of the asset is used it would not reflect the true 
value. Out of the three methods, this method may be the easiest option for 
companies to value R&D. However one must be mindful that cost and value is 
not the same thing. The value of something to a company is its ability to 
provide a generation of cash flows (Drever et al, 2007), whereas cost is the 
consideration paid to acquire goods or assets. 
 
The valuation methods applicable under IAS 38 refer to the following two models: 
• Cost Model – after initial recognition the benchmark treatment is that 
intangible asset should be carried at cost less any amortization or impairment. 
• Revaluation Model – intangible assets may be carried at a revalued amount 
based on fair value less any amortization or impairment.  However, this can 
only happen if fair value can be determined in relation to an active market. 
 
While it is worthy to note that the US GAAP requires intangible assets to be valued 
only on a fair value basis (SFAS 142 – Intangible Assets). But as the US does not 
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allow for capitalization of R&D the fair value method or any method is therefore 
irrelevant. 
 
2.5 R&D Tax Credit 
 
R&D affects peoples’ lives in so many ways; looking at the last decade we can see 
items including iPods and more important lifesaving devices like defibrillators being 
created.  R&D has become one of the most important activities that a business should 
undertake; therefore an R&D tax credit was introduced. This tax credit was 
introduced by the Government in many countries for companies that engage in R&D 
activities and is a significant attraction for locating R&D based companies.  Although 
this credit will not make non research and development companies take on R&D 
activities it can be a factor in determining where such R&D will occur (Hardy, 2009). 
 
The R&D tax credit is questioned by companies as to whether it adds value to 
companies or not. Each individual company is different as was seen with the 
capitalization of R&D expenditure; it has a positive effect on share price of some 
companies but a negative effect on others. Therefore, the R&D tax credit may be of 
benefit to certain companies.  
 
2.5.1 In Ireland 
 
Currently, Ireland is trying to focus on being an economy with greater R&D 
prospects, as it is believed to be a key to success and innovation. As stated by the 
Minister for Enterprise, Trade and Employment (2007), “research activity develops 
and engages people with the skills and innovative ideas capable of creating higher 
value-added products and processes which enhance competitiveness and will help our 
enterprise sector thrive in an increasingly competitive global market place” (Martin, 
2007). 
 
In Ireland, this tax credit is available for qualifying companies that take on 
incremental qualifying R&D expenditure in an accounting period. This credit is 
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available for offset against corporation tax payable by a company in the year the 
expenditure was incurred or can be used within a group structure. The credit can also 
be carried back and offset against corporation tax paid in the previous year, with any 
unused credits being carried forward indefinitely.   
 
Qualifying companies refers to organisations which: 
i. Carries on a trade; 
ii. Carries out R&D activities; and 
iii. Maintains a record of expenditure incurred by it, in the carrying out of 
those R&D activities (Finance Act 2009, section (s). 766). 
 
Qualifying R&D activities must: 
i. Be systematic, investigative or experimental activities within science or 
technology; 
ii. Seek to achieve scientific or technological advancement; and 
iii. Involve the resolution of scientific or technological uncertainty (Leyton, 
2010). 
 
The Irish R&D tax credit works on a rolling base year. Here Ireland’s base year is 
2003. This means that any current year qualifying expenditure is deducted from the 
expenditure incurred in the base year i.e. 2003, it is then on this figure that the tax 
credit is calculated. The R&D tax credit is 25% of this excess commencing on or after 
the 1
st
 January 2009, before this date the tax credit rate available was 20%. However, 
there are rules and regulations that are applicable in order for this tax credit to be 
claimed. For example, the R&D activities must be carried out by a company in the 
European Economic Area (EEA), the qualifying expenditure must be net of any grants 
which relate to the R&D activities being carried out and the companies have only 
twelve months from the end of their accounting period to file a claim (Finance Act 
2009, s. 766).  
 
This tax credit is not unique to Ireland but along with its low corporation tax rate at 
12.5% and other tax breaks such as no withholding taxes on interest or dividend 
payments, it makes Ireland an attractive location for multi-national companies 
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(MNC). Ireland is regarded as a world leader in both pharmaceutical and software 
exports with over 150 pharmaceutical companies, 50 biotechnology companies, 600 
software companies and 300 electronics companies. This has come about through a 
combination of innovative tax and economic policies (Fry, 2007). 
 
Although this tax credit gives companies additional relief due to engaging in R&D 
activities, the Innovation Taskforce Report (2010) wants the Irish Government to do 
more in order for Ireland to capture a greater share of the innovation activity globally. 
Commentators have criticised the rolling base year as being out of touch and out of 
date because some companies are at a disadvantage with this approach; especially in 
the economic downturn as their R&D expenditure could fall below what it was in the 
base year and no R&D tax credit could then be claimed (Flanagan and Hardy, 2009). 
 
The way in which the Irish R&D tax credit can be claimed is questioned, is the base 
year approach or the volume approach best? The differences between these two 
methods are: 
• Base year approach – this means that any expenditure in any year in excess of 
the expenditure incurred in the base year (i.e. 2003 for Ireland) qualifies for 
the relief (Doyle, 2010). 
• Volume approach – this means that all expenditure in full or over a certain 
amount qualifies for the relief. 
 
In Ireland, it would seem that the base year approach is disadvantageous to companies 
that were established before 2003 but this was not taken into account by the 
Government. Therefore should companies that have been formed longer lose out on 
the true extent of this tax credit? Or would a volume approach be best for companies 
to combat this problem for companies that are engaged in R&D.  
 
2.5.2 In the UK 
 
Within the UK, the R&D tax relief is available to all UK tax resident companies 
undertaking R&D activities. The relief is available to companies that spend over 
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£10,000 per annum on qualifying expenditure.  The UK has two R&D tax rates; one is 
in relation to small to medium enterprises (SME) and the other for large companies; 
• SME’s can deduct up to 175% of qualifying expenditure incurred after the 1
st
 
August 2008; and 
• Large companies can deduct up to 130% of qualifying expenditure after the 1
st
 
April 2008 (Leyton, 2010). 
 
The UK government believes that their R&D tax credit enhances the UK’s image as a 
destination for high value investment and jobs. It has contributed to creating a 
competitive environment for R&D and innovation in the UK (Darling, 2007). 
 
2.5.3 In the US 
 
The US R&D tax credit expired on the 31
st
 December 2009. The US does not have a 
continuous R&D tax credit; instead it opts for renewing this tax credit almost 
annually. So far this year, the extension of the R&D tax credit for 2010 has not being 
granted by the US congress.  
 
There is no current R&D tax credit in the US, but prior legislation included: 
• Providing a maximum 10% credit for qualified R&D expenditures in excess of 
a 1984-88 base (measures R&D expenditures against gross sales receipts for 
the period); 
• An Alternative Simplified Credit, providing a credit of 14% of R&D expenses 
that exceed 50% of average R&D expenses over the prior three years;  
• An Alternative Incremental Research Credit formula, which combines a three-
tiered fixed base percentage with a reduced three-tiered credit percentage 
(Ernst and Young, 2008). 
The business deduction for R&D expenses must be reduced by the amount of any 
R&D credit. 
 
Although in the US the R&D tax credit has not been extended yet as in other years, it 
is assumed that this tax credit will be reinstated. As this tax credit must be extended 
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almost annually, it affects companies that have projects with a life span of more than 
one year. By making the R&D tax credit permanent it will ensure that companies 
receive the full benefit of the tax credit. It remains unclear why the US does not have 
a rolling R&D tax credit. 
 
2.6  Conclusion 
 
The definitions of R&D under SSAP 13, IAS 38 and SFAS 2 are almost identical. 
These standards also share common examples of R&D activities. However, the 
accounting treatment of R&D differs between US GAAP, FRS and IAS. The 
differences between these accounting standards can be seen in the summary table 
below. 
 
Table 1  – Summary of the Accounting Standards for R&D 
 
 SSAP 13 IAS 38 SFAS 2 
Definition of 
Research  
Experimental or 
theoretical work 
undertaken primarily to 
acquire new scientific or 
technical knowledge for its 
own sake rather than 
directed towards any 
specific aim or application. 
Original and planned 
investigation undertaken 
with the prospect of 
gaining new scientific or 
technical knowledge and 
understanding. 
Planned search or critical 
investigation aimed at 
discovery of new 
knowledge, with the hope 
that such knowledge will 
be useful in developing a 
new product or service, or 
a new process or 
technique, or bringing 
about a significant 
improvement to an 
existing product or 
process. 
Research 
Activity 
Examples 
• Activities such as laboratory research, aimed at obtaining new knowledge; 
• The search for, evaluation and final selection of applications of research 
findings or other knowledge; and 
• The search for alternatives for materials, products or systems services. 
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Definition of 
Development 
The use of scientific or 
technical knowledge in 
order to produce new and 
substantially improved 
materials, devices, 
products or services, to 
install new processes or 
systems prior to the 
commencement of 
commercial applications, 
or to improve substantially 
those already produced or 
installed. 
Application of research 
findings or other 
knowledge to a plan or 
design for the production 
of new or substantially 
improved materials, 
devices, products, 
processes, systems or 
services prior to the 
commencement of 
commercial production or 
use. 
Translation of research 
findings or other 
knowledge to a plan or 
design for a new product 
or process, or for a 
significant improvement to 
an existing product or 
process, whether intended 
for sale or use. 
Development 
Activity 
Examples 
• The design, construction and testing of pre-production or pre-use prototypes 
and models; 
• The design of tools, jigs, moulds and dies involving new technology; 
• The design, construction and operation of a pilot plant that is not of a scale 
economically feasible for commercial production; and 
• The design, construction and testing of a chosen alternative for new or 
improved materials, devices, products, processes, systems or services to the 
point that they meet specific functional and economic requirements and are 
ready for manufacture. 
Capitalization 
of Research 
Not allowed, therefore must be expensed. Other than under IFRS 3 Business 
Combinations. 
 
Capitalization 
of 
Development 
Development may be 
capitalized if it meets 
certain criteria. This is at 
the managements’ 
discretion.  
Development must be 
capitalized if it meets 
certain criteria. 
Not allowed, therefore 
must be expensed. 
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Since 2002, the convergence process has been rather slow. It does not seem to be a 
priority for either the FASB or the IASB. Therefore, it is clear that convergence in 
relation to R&D will not occur for at least another few years.  Hence, SSAP 13, IAS 
38 and SFAS 2 will remain the accounting standards used in Ireland, the UK and the 
US for R&D until the convergence process is complete. The convergence must 
discuss whether capitalization of development expenditure should be permitted or not.  
The IASB decided that the IFRS for SME’s would treat all R&D costs as an expense 
to the statement of comprehensive income. Alternatively, SME’s could apply the 
requirements of IAS 38 by a cross-reference to the IFRS (IFRS for SME’s, 2009). 
Therefore, it is unclear what decision the IASB will take on the convergence process. 
However, if capitalization of R&D is authorised then the correct valuation method 
needs to be decided to assist companies when placing a value on R&D expenditure.  
 
R&D expenditure is high globally. In 2008 the top 1,400 global companies spent 
approximately £274 billion on R&D expenditure (The 2008 R&D Scoreboard, 2008). 
This being said, the R&D tax credit has been essential in keeping a competitive global 
economy. It enhances a company’s ability to bring more products and services to the 
market place.  
 
The R&D tax credit has been shown to be effective at increasing R&D expenditure, 
and as research has shown that R&D is a key to boosting economic growth (Lev and 
Sougiannis, 1996). Therefore, maintaining or even increasing the R&D tax credit will 
encourage companies to perform more R&D in Ireland and also globally. This will 
leave companies in a better position to innovate and compete successfully in national 
and international markets. 
 
Finally, this chapter provided the reader with an overview of the literature that is 
relevant to the author’s research topic. This literature review covered the accounting 
treatment of R&D in Ireland, the UK and the US, the problems with convergence of 
accounting standards, the valuation of R&D and the R&D tax credit. The literature 
review provided the author with information about past and current research in the 
area of the research topic. This has helped the author refine their research question 
and objectives, which are as outlined in section 1.4 and 1.5. 
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Chapter 3 – Research Methodology 
 
3.1 Introduction 
 
Methodology describes “how an individual piece of research is conducted” (Brennan, 
1998 (Pg: 37)).  The purpose of including a methodology section is to outline how the 
researcher plans to carry out their research, including the author’s research question, 
objective, research strategies, data collection techniques and why the strategies and 
techniques are suitable to answer the research question posed. 
 
In this section the researcher will outline their research question, research objectives, 
research design and finally provide a summary and conclusion. 
 
3.2 Research Question 
 
The research methodology required must be capable of helping the researcher answer 
the following research question: 
“How Research and Development is accounted for Ireland by companies listed on the 
Irish Stock Exchange (ISEQ)?” 
 
3.3 Research Objectives 
 
The author’s research objectives are derived from the research question, and are what 
the researcher hopes to achieve from doing this research. The objectives are: 
• To compare and contrast how R&D is accounted for in Ireland, the UK and 
the US and the impact of future convergence by global standard setters.  
• To examine how the valuation of R&D is important.  
• To establish what influence the R&D tax credit has on companies. 
• To determine what Ireland is like as a R&D economy. 
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3.4 Research Paradigms 
 
The research paradigm is the general approach to research. Collis and Hussey (2003, 
Pg: 46) state the term paradigm refers to ‘the process of scientific practice based on 
people’s philosophies and assumptions about the world and the nature of 
knowledge…about how research should be conducted.’  
 
The two main paradigms are positivism and interpretivism which are explained 
below. 
 
3.4.1 Positivism 
 
Positivism is based on the concept that similar studies should be comparable and 
achieve the same results where there is one truth, and one truth only. Positivism is a 
structured approach to collecting data, which is analysed and interpreted. Positivism 
implies that the researcher is “working with an observable social reality and that the 
end product of such research can be the derivation of laws or law-like generalizations 
similar to those produced by the physical and natural scientists” (Remenyi et al, 2003, 
(Pg: 32)). 
 
3.4.2 Interpretivism 
 
Interpretivism is a qualitative research method that studies human experiences and 
consciousness. It is the study of how things appear in our experiences, the way we 
experience things and therefore the meaning things have in our experiences (Hair et 
al, 2007). 
 
3.4.3 Research Paradigm Adopted 
 
Selection of the correct philosophy is crucial to the research outcome, and is 
determined by the way in which the researcher thinks about the development of 
knowledge. Justification of the researcher’s philosophy will depend on the nature of 
the researcher’s objectives and their desired outcomes. After studying the literature, 
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the researcher has concluded that a mixed method approach will be used as both 
paradigms – positivism and interpretivism will be used in this research.  
 
Semi-structured interviews are interpretative in nature and questionnaires are of a 
positivistic nature as the results can be analysed into percentages. The study involved 
the researcher interpreting the opinions of the interviewees in Chapter 4. 
Interpretivism allows the understanding of why and how data is collected however; 
the findings are open to the researcher’s bias. Questionnaires are quantifiable in 
nature by the use of yes/no answers in their structured nature, therefore assuming a 
reduction on researcher bias.  
 
3.5 Research Approach 
 
When doing research the author must decide on the research approach that will be 
undertaken in order to answer the research question. There are two possible 
approaches to research depending on the outcome that your want from your research. 
These approaches are inductive and deductive. 
 
3.5.1 Inductive Research 
 
Hussey and Hussey (1997) express that if the aim of the research is to develop a 
theory, then an inductive approach should be used. The inductive approach involves 
gaining an understanding of the meaning humans attach to events. 
 
3.5.2 Deductive Research 
 
A deductive approach is used if you want your research to prove a theory or 
hypothesis. It is based on scientific principles and involves the development of a 
theory that is subject to rigorous testing (Saunders et al, 2007). 
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3.5.3 Research Approach Adopted 
 
The author will be using a combination of both a deductive and an inductive 
approach, because the aim of the research is to see how Irish listed companies account 
for R&D, to determine what problems these companies have with the valuation of 
R&D, to establish if they are availing of the R&D tax credit and to determine what 
Ireland is like as an R&D economy.  A deductive approach will enable the author to 
collect data that can be quantified and will result in a conclusion that generalises 
about the entire population as a whole. Whereas, an inductive approach will allow the 
author to qualify data that will be unique to the population. 
 
3.6 Research Focus 
 
Research focus varies depending on the purpose of the research. The purpose of the 
research could be exploratory, descriptive, or explanatory, or could be more than one 
of these.  
 
3.6.1 Exploratory Research 
 
Exploratory research is one that “aims to seek new insight into phenomena” 
(Saunders, 2007 (Pg: 598)). It is aimed at trying to find out what problems exist if 
any. Exploration is particularly useful when the researcher is unclear of what 
problems might arise during the study (Coldwell and Herbst, 2004).  
 
3.6.2 Descriptive Research 
 
Descriptive research is one that produces an accurate representation of persons, events 
or situations. It tries to answer the questions who, where, what, when and how (De 
Vaus, 2002).  
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3.6.3 Explanatory Research 
 
Explanatory research is one that studies a “situation or a problem and tries to explain 
the relationship between the variables” (Saunders, 2007 (Pg: 598)). It tries to explain 
why things happen and not just what happens but how. 
 
3.6.4 Research Focus Adopted 
 
The author has decided to adopt an exploratory and descriptive approach to this 
research because the author is trying to gain both qualitative and quantitative 
information. The exploratory approach is used by the researcher to find out how R&D 
is treated in the financial statements of listed companies, this will be done through the 
questionnaire responses and by analysing the financial statements from the companies 
annual reports. 
 
A descriptive approach will be adopted by conducting semi-structured interviews and 
also by using the questionnaires, were the respondents will be able to express their 
views on matters such as the accounting treatment of R&D, valuation of R&D, tax 
credits for R&D and Ireland as an R&D economy. 
 
Once the research focus and the research approach has been decided upon it will then 
be necessary to decide on what data collection methods the author will implement to 
carry out the research. 
 
3.7 Data Collection Methods 
 
The two data collection methods used by the researcher for this project are primary 
and secondary research. These are used as most research requires a combination of 
both secondary and primary research in order to answer the research question and its 
objectives. 
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3.7.1 Secondary Research 
 
Secondary data includes both qualitative and quantitative data that has arisen from 
previous works undertaking (Malhotra, 2007).  Finding secondary research involves 
establishing the correct information that is suitable and valid to the dissertation and 
then locating this data.  
 
There are numerous forms of secondary research available; they have been broken 
into three forms namely documentary, survey and those from multiple sources 
(Saunders et al, 2007). However, the secondary research conducted by the author 
included reviewing articles, academic journals and books to find the most suitable 
literature.  In carrying out the secondary research, the financial statements of Irish 
listed companies and 10 companies from the Pharmaceutical and Food sector of the 
UK’s Financial Times Stock Exchange (FTSE) were examined to determine the 
accounting and amount of R&D; however, the researcher intends to use this research 
on a primary research basis. 
 
There are several advantages of gathering secondary research; it is easily accessible, 
relatively inexpensive and quickly obtained. It also has its disadvantages as well, 
including that it is not tailor made to fit this research, therefore the author must ensure 
that the secondary research is “reliable and valid” (Sumser, 2001, (Pg:10)). The 
researcher only included secondary data which she found to be reliable and valid, this 
included peer reviewed articles, books, government studies and financial statements 
(however it is questionable if financial statements are reliable and valid). 
 
3.7.2 Primary Research 
 
There are three main methods for the collection of primary data – observation, 
questionnaires and interviews. The collection method used is at the discretion of the 
researcher as long as they are able to obtain the information to answer the research 
question, however Kumar (1999) states that the method chosen depends on the 
purpose of the research, the resources available, and the skills of the researcher. This 
research is focusing on financial statements, questionnaires and interviews as its 
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primary data collection, as observation was not a suitable choice given the research 
question and its objectives. 
 
3.7.2.1 Questionnaires 
Questionnaires are one the most efficient method of collecting in terms of time and 
money (Hair et al, 2007). They are an inexpensive way of generating large amounts of 
information from a large number of people, to whom a standard set of questions is 
issued for completion. There are two types of questions that can be used in 
questionnaires: 
• Closed questions – the researcher provides a set of responses from which the 
respondent must choose. Typical responses to closed questions are yes/no or 
multiple choice option, ratings and rankings. 
• Open-ended questions – in these types of questions no options are available 
for the respondent to choose. It is designed to encourage revealing attitudes or 
obtaining facts (Grummitt, 1980). 
 
The key to a successful questionnaire is in its design, regardless of which types of 
questions are used. The questions should be clear, concise and unambiguous. This 
eliminates problems associated with wrongly interpreting the questions. The 
researcher should avoid using certain types of questions that lead the respondents to 
choose a particular answer. 
 
Questionnaires have the advantage of being completely anonymous and they are 
probably the most inexpensive way of generating the required information. However, 
they are considered to be a very impersonal way of collecting data. There is no face-
to-face interaction between the researcher and the respondent. Because of this, the 
response rate may be low and responses from the questions short. Also, questionnaires 
do not allow the researcher to see the full picture as it does not allow for the 
correction of any misunderstandings or probe further response. 
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3.7.2.1.1 Questionnaire Design 
It was decided that the questionnaires would be issued to Irish listed companies as the 
population for non-listed companies is too large and a representative sample may be 
hard to obtain (see Appendix 1 for list of companies on the ISEQ). Therefore the 
entire population was surveyed making this a census rather than a sample. A total of 
63 questionnaires were issued with 20 complete and 2 partial responses received.  
 
The researcher chose questionnaires due to time and financial constraints to give the 
most suitable and valuable information for her primary research. It was first thought 
that the questionnaires could be distributed by email but the researcher was unable to 
obtain all the companies email addresses, so instead all questionnaires were posted 
out to the companies, along with a return stamped addressed envelope. 
 
The questions used for the questionnaire were designed by a combination of the 
researcher, Business Expenditure on Research and Development (BERD) Survey 
2007/2008, a survey conducted by Bill Nixon. The questions relate back to the 
secondary data collected and to the research question and objectives. It was important 
to ensure that the questions were clear, understandable and unambiguous, therefore 
the questionnaire was pilot tested before sending out to the population. The questions 
yielded both qualitative and quantitative information and had a combination of both 
open-ended and closed questions. A copy of the cover letter sent with the 
questionnaires and the questionnaire and can be found in Appendix 2&3 respectively. 
 
Initially, the researcher had chosen to use questionnaires as the main means of data 
collection, however, due to the problems listed above it was decided that more 
detailed information was required. Therefore, the researcher also conducted a number 
of interviews. 
 
3.7.2.2 Interviews 
Interviews are used when we want to investigate or understand someone’s feelings, 
experiences or learn more about answers they may already have given. Interviews can 
be conducted on the telephone or face-to-face. There are three main types of interview 
techniques that are used in research – structured, semi-structured and unstructured. 
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The structured interview is used to discover people’s views on a predetermined set of 
topics. Here the same set of questions is asked to all interviewees. In a semi-structured 
interview the researcher has a list of themes and asks questions to prompt answers 
from the interviewee. Unstructured interviews have no predetermined set of questions 
or topics. This latter type of interview is very informal and more like a conversation 
on a specific topic between two people rather than an interview. 
 
3.7.2.2.1 Interview Design 
Each interview technique has its advantages and disadvantages depending on the type 
of interview required. The researcher did not want a too rigid interview or an 
interview that was of no relevance for primary research. Therefore it was decided that 
a semi-structured interview would be best to obtain sufficient information. This 
allowed the researcher to direct questions or themes at the interviewee, while at the 
same time allowing the conversation to flow so as to let the interviewees express their 
thoughts freely. 
 
The interviews are being used to get a better insight into the accounting treatment for 
R&D, valuation of R&D, tax credit for R&D and Ireland as an R&D economy. Two 
semi-structured interviews were held. The interviewees included: 
• Professor of Accounting and Finance at a top Irish University. 
• An accountant that was able to help with the accounting treatment of R&D 
and their opinion of what Ireland is like as an R&D economy. 
 
An interview guide was drawn up (see Appendix 4) to ensure that the researcher 
obtained the relevant information from all interviewees, however, this was only a 
guide and additional questions were also asked as not all questions were applicable to 
all interviewees. The interviews were conducted by the researcher in July 2010; each 
interview varied in length but lasted between thirty to forty-five minutes. The 
interviews were not tape recorded. However, the researcher also took hand written 
notes on important areas while listening intently. The interview guide was sent to all 
interviewees in advance so that they would have the opportunity to prepare for the 
interview. The researcher hoped that this would not result in rehearsed responses that 
did not reflect their true views or beliefs.  
RESEARCH METHODOLOGY 
 32 
3.7.2.3 Triangulation 
Triangulation refers “to the use of different data collection techniques within one 
study in order to ensure that the data are telling you what you think they are telling 
you” (Saunders et al, 2007 (Pg: 139)). The use of triangulation added to the 
researchers’ primary data collection. Here the researcher used triangulation by 
comparing the financial statements of listed companies with the responses to the 
questionnaires received from them. The financial statements gave the researcher an 
indication of how the companies dealt with R&D and by using triangulation she could 
see if what they did in reality was the same as they said they were doing.  
 
3.8 Data Analysis 
 
The data was analysed using a combination of three data collection methods. These 
being: 
1. Questionnaires – the responses were analysed using tables and graphs such as 
pie and bar charts so that the answers can be clearly understood by the use of 
visual aids rather that lengthy descriptive paragraphs. This can be achieved 
using Microsoft Excel, which is quick and easy to use. The reader should have 
no problems understanding this method of data analysis; therefore it is an 
appropriate method.  
2. Interviews – these were used as quotes or paraphrased in the text in order to 
give a clearer understanding to answering the research objectives. These can 
also be analysed by percentages e.g. yes/no answers. 
3. Financial Statements – by using the financial statements it will be clear to the 
reader what percentage of intangible assets are in relation to R&D. The 
comparison with the UK companies will help establish whether or not the Irish 
listed companies are on par with other companies in the same sector, and also 
if the same accounting treatment applies. 
 
3.9 Ethical Consideration 
 
Good ethical practice requires that all research is conducted on the basis of respect for 
and adherence to regulatory guidelines and internationally accepted ethical norms 
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focusing on the welfare of the study participators. In order to follow this, the 
researcher had to fill out the college’s ethical policy and procedure application and 
have it approved by an ethical committee before engaging in any primary research. 
When performing research it is important that the researcher takes into consideration 
all ethical issues which may affect any respondents. The researcher conducted all 
primary research with professional integrity and strict confidentiality. With regard to 
both the interviews and the questionnaires, the researcher ensured that interviewees 
and respondents would remain anonymous and their views would be confidential.  
 
3.10 Conclusion 
 
This chapter provided an overview of the methodology used to carry out the author’s 
research. The chapter included information on how the questionnaire and interviews 
were designed, how the population and sample were chosen and how the author 
intended to use the financial statements of listed companies. It outlines how the 
questionnaire was distributed and how the interviews were conducted and also 
included the possible limitations that the author’s research faces. The main findings 
from this research are discussed in Chapter 4. 
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Chapter 4 – Data Analysis and Findings 
 
4.1 Introduction 
 
The aim of this chapter is to present the results of the questionnaire (see appendix 5) 
and interviews that the author has carried out as part of this research and the data 
collected in the financial statements of all 63 companies listed on the ISEQ and 10 
companies specialising in the Pharmaceutical and Food Industry on the FTSE. The 
author will outline the results that were obtained, then will analyse these results and 
will discuss what these results mean and how these results compare to other research 
carried out on this topic and what has been published in journal articles. 
 
4.2 Respondents 
 
The questionnaire was carried out by post with the respondent given a return stamped 
addressed envelope to complete the questionnaire. The author got the addresses of the 
respondents from the Company Registration Office (CRO). The author sent a total of 
63 questionnaires and received a total of 20 full responses and 2 partial responses. 
This gives the author a response rate of 32%. The partial responses were not included 
in the results. Of the 20 respondents, 11 (55%) undertook R&D. 
 
The questionnaires were addressed directly to the CFO and all but two responses were 
received from the CFO, the other two being received from Group Controllers. The 
author is happy with the people who completed the questionnaire and feels that they 
all have suitable knowledge to answer the questions posed to them in the 
questionnaire. As a result of this the author believes that there is no need to exclude 
any of the participants. 
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Table 2  – Respondents positions within organisations 
 
Position within the organisation Number % 
CFO 18 90 
Group Controller 2 10 
Total 20 100 
 
The participants all ranged from a variety of business areas such as Pharmaceuticals, 
Food and Construction, etc. The breakdown of businesses that completed the 
questionnaires is as follows: 
 
Table 3 – Industry sectors which the respondents operate 
 
Industry Number % 
Pharmaceuticals 2 10 
Food 2 10 
Construction 2 10 
Technology 3 15 
Financing 0 0 
Other 11 55 
Total 20 100 
 
A total of two semi-structured interviews were conducted. The interviewees included: 
• Interviewee A – Professor of Accounting and Finance at a top Irish University. 
• Interviewee B – An accountant who was able to help with the accounting 
treatment of R&D and their opinion of what Ireland is like as an R&D 
economy. 
  
In relation to the financial statements obtained from all 63 companies listed on the 
ISEQ, only 6 companies (9.5%) capitalized development expenditure, with a total of 
16% expensing R&D expenditure to the statements of comprehensive income. The 10 
companies on the FTSE all engaged in R&D but none of the companies capitalized 
development expenditure, therefore they all expensed R&D expenditure to the 
statement of comprehensive income. 
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4.3 Data Analysis and Findings 
 
4.3.1 Research Objective 1 
 
“To compare and contrast how R&D is accounted for in Ireland, the UK and the US 
and the impact of future convergence by global standard setters.”  
 
The aim of this objective was to find out how R&D is accounted for in the financial 
statements of Irish listed companies. In Chapter 2 the accounting treatment for R&D 
in Ireland, the UK and the US was discussed in detail as was the impact of future 
convergence by global standard setters, which in theory answers this research 
objective. However, whether companies are following these standards is a different 
issue and this is why the author obtained the financial statements of Irish and UK 
listed companies, issued questionnaires and conducted interviews on this subject area. 
 
4.3.1.1 Findings 
The financial statements of the Irish listed companies that conducted R&D showed 
that all companies make reference to the policy in respect to accounting for R&D; 
however the amount of disclosure differed among companies. For example Datalex 
Public Listed Company (PLC) provided a detailed accounting policy: 
 
“Research expenditure is recognised as an expense as incurred. Directly attributable 
costs incurred on development projects (relating to the design and testing of new or 
improved products) are recognised as intangible assets when the following criteria are 
fulfilled: 
i) It is technically feasible to complete the intangible asset so that it will 
be available for use or sale; 
ii) Management intends to complete the intangible asset and use or sell it; 
iii) There is an ability to use or sell the intangible asset; 
iv) It can be demonstrated how the intangible asset will generate probable 
future economic benefits; 
v) Adequate technical, financial and other resources to complete the 
development and to use or sell the intangible asset are available; and 
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vi) The expenditure attributable to the intangible asset during its 
development can be reliably measured. 
 
Other development expenditures that do not meet these criteria are recognised as an 
expense as incurred. Development costs previously recognised as an expense are not 
recognised as an asset in a subsequent period. Capitalised development costs are 
recorded as intangible assets and amortised from the point at which the asset is ready 
for use on a straight-line basis over its useful life of three to five years” (Datalex PLC, 
2008 (Pg: 34)). 
 
This is in agreement with the literature found in 2.3.3 as it states that if development 
expenditure meets the criteria then it must be capitalized, otherwise it is charged as an 
expense to the statement of comprehensive income, along with any research 
expenditure.  
 
The author asked respondents of the questionnaire what specific elements of R&D 
they carry out within their organisation in order to see if there would be any problems 
in defining R&D as set by the accounting standards. These were split into basic 
research, applied research, development only or R&D. The most common result was 
R&D with 82% of the respondents choosing this option. Only 18% respondents 
selected development, with no respondents choosing either basic or applied research. 
 
Figure 1 – Types of R&D carried out 
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This helps to see if companies would find it difficult to separate research expenditure 
from development expenditure. When asked this question 40% of the respondents 
agreed that they find it hard to separate the two, mainly because they are too closely 
linked. This is one of the explanations the literature gives for the US expensing all 
R&D expenditure as companies are unable to separate the two.  
 
While it is clear from the literature that the IAS’s does not allow for the capitalization 
of research expenditure, respondents were asked if their company capitalized 
development expenditure. The reason given in the financial statements of the UK 
listed companies for not capitalizing development expenditure was that they did not 
meet the criteria for IAS 38. However, in Ireland, the results concluded that 60% of 
the respondents did not capitalize development expenditure. 
 
Figure 2 – Capitalisation of development expenditure 
 
 
Out of the 6 respondents that did not capitalize development expenditure, 5 agreed 
that it was because they did not meet the criteria. While the other respondent stated 
the reason that they do not capitalize development expenditure was because “it is 
easier for stakeholders to understand as shareholders prefer a simpler balance sheet”. 
However, interviewee B expressed that if companies meet the criteria for 
development they must expense it as “the accounting standards are strong so there is 
reason not to follow them”. 
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This lead to the question whether or not the accounting standards could be 
manipulated to allow companies to account for development expenditure in the way 
they preferred. This reflects what has been reviewed in the literature in that, 
capitalization or amortization of development expenditure is at the managers’ 
discretion (Monahan, 2003). All but one of the respondents from the questionnaires 
believed that the accounting standards could not be manipulated as “guidance is very 
clear in the standard” and that the “criteria for capitalizing R&D is very specific and 
does not really provide any room for manoeuvre”. However interviewee A is not of 
the same opinion, as was one of the respondents of the questionnaires who felt that 
companies could manipulate if they so wished as “there is a number of ways to 
interpret the standard based on output of R&D”.  
 
Over half of the respondents (60%) have a dual stock market listing, some with the 
UK and others with the US. The respondents with dual stock market listing with the 
UK face no problems with the accounting treatment for R&D as the same accounting 
standard (IAS 38) governs both. 
 
4.3.1.2 Analysis and Discussion 
The results regarding the accounting treatment of R&D are in conjunction with the 
literature found in Chapter 2 by Irish listed companies. The IASB requires all Irish 
listed to follow IAS 38 in relation to R&D. The author agrees, from both analysing 
the financial statements and from the questionnaires, this is what these companies are 
undertaking. 
 
The response in relation to whether or not companies manipulate the account 
standards is not in support of the literature found by the researcher. It must also be 
expressed that this result is what accounting standard boards want to see, so that they 
know they are achieving their goal as standard setters, which may help in their bid for 
global convergence. 
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4.3.2 Research Objective 2 
 
“To examine how the valuation of R&D is important.”  
 
This objective was designed in order to establish what valuation should be placed on 
R&D. One of the criticisms of this is that if it is not physical and it cannot be seen, 
then how is R&D meant to be valued. From the literature it is clear that R&D is 
important for many reasons such as economic growth and general day-to-day needs of 
people, therefore if R&D is important then its valuation must also be important. 
 
4.3.2.1 Findings 
Companies spend a great deal of money on R&D, the extent of this varies among 
companies as can been seen when the author asked the respondents of the 
questionnaire how much per annum do they spend on R&D. 
 
Figure 3 – R&D spend by Irish Companies 
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Overall it is clear that companies spent a large amount of money on R&D. From 
analysing the financial statements of all 63 companies on the ISEQ, the total amount 
spent on capitalized R&D in 2008 was around €88 million.  However, this amount 
only accounts for 5% of total intangible assets and a mere 0.5% of total assets. 
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There are a lot of costs involved with R&D, one being the cost of labour. The author 
asked the respondents how many employees are involved in the R&D process. The 
results were: 
 
 
Figure 4 – Number of employees involved with R&D 
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This graph shows that the majority of companies (64%) employ more than 20 
employees for R&D. The author did not come across any literature that focused on 
this area of discussion but she found it interesting to see how many jobs were created 
for R&D alone by listed companies. 
 
However, the author was able to find a vast amount of literature not only on the 
valuation of items in general as it is one of the contemporary issues in accounting 
(Drever et al, 2007) but also on the valuation of R&D. The author asked the 
respondents of the questionnaires on how they valued the R&D undertaken. 90% of 
the respondents valued R&D at cost, with 10% valuing R&D at fair value. It was not 
specified how fair value was based. The literature found that it was difficult to 
determine a valuation of R&D due to the uncertainties of future benefits and 
economic life, although both the cost model and fair value model is regarded as 
acceptable (IAS 38). Interviewee B believes that R&D should be valued at cost as 
“fair value is difficult to work out as it is based on a projection of present value and it 
is extremely subjective”. 
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It is believed that the capitalization of development costs has an effect on share price; 
therefore if this is found to be true, then an appropriate valuation must be placed on 
R&D. The researcher asked the respondents of the questionnaires if they also feel that 
the capitalization of development costs had an effect on share price. 
 
Figure 5 - Does the capitalization of development costs have any effect on 
share price? 
 
11%
0%
89%
A positive effect on share
price
A negative effect on share
price
No effect on share price
 
 
The popular answer with the respondents was that the capitalization of development 
costs has no effect on share price. 11% believed that capitalization has a positive 
effect on share price which agrees with the literature researched that found a strong 
positive correlation between financial statement information and the market value of 
equity when R&D is capitalized compared to notional expensing (Hirschey and 
Weygandt, 1985 and Smith et al., 2001). Interviewee A stated that he “did not know 
that share price was largely affected by analysts who had a biased outlook on what to 
say in relation to a company’s performance”. 
 
4.3.2.2 Analysis and Discussion 
The results for this objective of whether or not the valuation of R&D is important 
concluded that the valuation of R&D is extremely important. The valuation of R&D 
impacts on other key aspects of a company’s existence such as the statements of 
comprehensive income if R&D is expensed or amortized or the statement of financial 
position if R&D is capitalized. The valuation of R&D in these two instances impact 
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on reserves and a profit or loss for a company which in turn will affect future spend 
on R&D if it is not seen as a good opportunity for the company. There are numerous 
options available for companies to value R&D at, as can be seen in Chapter 2 but it is 
again at the managers’ discretion which option is used. 
 
The findings of the impact development capitalization has on share price did not 
reflect that of literature researched. The literature found on this matter was unable to 
give a clear answer as to whether it had a positive effect (Sougiannis, 1994) or a 
negative effect (Kallunki et al, 2009) on share price, but from the responses from the 
questionnaires, the respondents feel that capitalization of development has no effect 
on share price. 
4.3.3 Research Objective 3 
 
“To establish what influence the R&D tax credit has on companies.” 
 
The goal of this objective was to determine what influence the R&D tax credit has on 
companies, as the R&D tax credit is said to be means of encouraging businesses to 
engage in R&D activities. Also, the author wanted to investigate whether the base 
year approach or the volume based approach is regarded as the best. 
 
4.3.3.1 Findings 
60% of the respondents of the questionnaires avail of the Irish R&D tax credit. The 
remaining respondents stated that the reason that they do not avail of the R&D tax 
credit was because of the following reasons: 
• That the criteria for the tax credit does not apply; 
• That the company is not currently engaged in R&D activity in Ireland, but are 
carrying out R&D abroad; 
• That there is not enough expenditure in Ireland to justify claiming this credit; 
and 
• That the expenditure in the base year was high and the company has not 
reached this amount since. 
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All but one respondent feels that this tax credit is of value to companies as they feel 
that “it is more suitable for relatively new companies as the base year is 2003 and we 
had a lot of spend that year”.  
 
Figure 6 – Is the R&D tax credit valuable to companies? 
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All the respondents felt that the R&D tax credit is an incentive for companies to 
engage in additional R&D as “the marginal cost of additional resources is reduced” 
and that the tax credit “is far better than grants”.  However, interviewee A said that 
although the tax credit is an incentive for companies, grants to conduct R&D should 
also be considered as an incentive.  
 
From the literature for the R&D tax credit among countries differ on amounts and on 
what approach is used. The author asked the respondents of the questionnaires if they 
think that Ireland’s base year approach is a good idea or should it be more volume 
based like the US when its R&D tax credit was in effect. 
 
 
 
 
 
 
 
DATA ANALYSIS AND FINDINGS 
 45 
Figure 7 – Is the base year approach of Ireland’s R&D tax credit a good 
idea? 
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Many of the comments on this question related to how unfair it was to older 
companies set up in Ireland before 2003 and that a volume based approach would “be 
a truer reflection of real costs incurred”. This is in agreement with the literature which 
concluded that the base year approach is of a disadvantage to some companies, 
especially in the economic downturn that Ireland is facing (Flanagan and Hardy, 
2009). Interviewee B feels that the current R&D tax credit system in place is 
sufficient, with interviewee A disagreeing that this approach is better suited to new 
companies only. 
 
4.3.3.2 Analysis and Discussion 
The results shown for this objective are in unison with the literature found. It is clear 
that the Irish R&D tax credit is of value to companies as so many companies claim the 
R&D tax credit. Therefore, if it so popular in Ireland it still remains unclear why the 
US keeps eliminating the R&D tax credit there, as it would have a more immense 
number of companies in the innovation and R&D sector than Ireland.  
 
Also, as the literature found, the base year approach Ireland undertakes is not 
favoured by the majority of the respondents. This means that the Irish Government 
may make the changes that the Innovation Taskforce Report (2010) has presented in 
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order to do more in order for Ireland to capture a greater share of the innovation 
activity globally. 
 
4.3.4 Research Objective 4 
 
“To determine what Ireland is like as a R&D economy.” 
 
This objective wanted to establish if Ireland is regarded as a good place for 
conducting R&D, as some research has shown that Ireland is not as globally active as 
other countries (The R&D Scoreboard, 2008).  This also hopes to achieve if they are 
any problems of carrying out R&D in Ireland and what other locations are more 
favourable. 
 
4.3.4.1 Findings 
Only one of the respondents of the questionnaires (6%) felt that Ireland was not a 
good place to conduct R&D as “the incentives are not good enough”. 
 
Figure 8 – Is Ireland a good place to conduct R&D? 
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The main reasons that the respondents feel that Ireland is a good place to conduct 
R&D has been classified into three categories: 
1. Employees – the qualifications and skills of the workforce. 
2. Taxation - good tax regimes and low rate of corporation tax. 
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3. Location – a gateway to the EU. 
However, when asked are there any impediments of carrying out R&D in Ireland the 
respondents of the questionnaires felt that Ireland had a lot of problems. These 
included the costs of labour and goods, the unavailability of senior R&D staff, lack of 
emphasis of science in schools, limitation of Government grant assistance, language 
barriers and locating laboratory facilities. All these play a major role on companies 
partaking in R&D, and must be fully assessed before companies decide where to 
locate for R&D activities. 
 
Table 4 – What locations, other than Ireland, is good for R&D activities?  
 
 
When asked what improvements could be made to make Ireland more R&D friendly, 
the answers from the respondents of the questionnaires covered the following areas: 
• An increase in the R&D tax credit and other tax incentives; 
• Moving away from the base year tax credit; 
• Increasing language skills and training; 
• Stabilising national finances as to give MNC’s more security;  
• More support from the Government to encourage R&D activity; and 
• Introducing more subsidies, that could fund facilities for R&D that companies 
can use. 
 
Interviewee B suggests that an increase in the awareness of the R&D tax credit is 
needed so that smaller companies know that this tax credit exists. 
 
More favoured locations for R&D  No. of Respondents 
Eastern Europe 2 
US 6 
India 3 
China 2 
Israel 1 
Luxembourg 1 
Netherlands 1 
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Overall the current recession is a big factor in the decisions that both companies and 
the Government make. Therefore, the author asked the respondents of the 
questionnaires if the recession has had a positive or negative effect on the amount of 
R&D companies undertake. The results showed that 37% felt that the recession has 
had a positive effect on R&D. 
 
Figure 9 - What effect has the recession had on R&D? 
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Interviewee A is of the opinion that the recession will have a negative effect on R&D 
activity. He believes that cut backs will need to be made and normally this starts 
“firstly with advertising, secondly with training and then R&D as these are 
discretionary items”. He also expressed that Pharmaceutical companies can not afford 
to make R&D one of their cut backs. 
 
4.3.4.2 Analysis and Discussion 
This objective has not been discussed in any great length in the literature; therefore 
there has been no cross reference between the findings and the literature. The results 
of this objective are quiet clear that Ireland is a good place to conduct R&D but it has 
it flaws. Many of the reasons that companies find faults in Ireland for R&D purposes 
are similar to the areas they have suggested for improvements to make Ireland more 
R&D friendly.  
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The US was a predominant choice for a better location than Ireland for R&D; the 
author felt that this answer was in concurrence with The R&D Scoreboard 2008 as out 
of the top 20 R&D companies 35% had a US origin. This was 20% ahead of any other 
country.  The recession will not impact on Ireland alone, as this is a global problem 
and all countries will be feeling the effects of it. 
 
4.4  Conclusion 
 
This chapter presented the findings of the author’s research. The author then analysed 
and discussed the findings. The author found that companies listed on the ISEQ were 
following the accounting standards set by the IASB when accounting for R&D and, 
contradictory to the literature, these companies did not feel that they could manipulate 
the standards. The results showed that the cost model was the valuation method 
mostly used for R&D and that the capitalization of R&D had no effect on the share 
price of companies. The author also found that although the Irish R&D tax credit is 
being used it has its problems, one being the base year approach. Finally, the author 
found that while Ireland is regarded as a good location to conduct R&D largely due to 
its tax regimes, other locations such as the US is also preferred.  
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Chapter 5 – Conclusion and Recommendations 
 
5.1 Introduction 
 
The purpose of this chapter is to provide the reader with a summary of what the 
research found and the conclusions that the author has arrived at after carrying out this 
research. This chapter will include a conclusions, the authors’ reflection of the 
learning experience and areas for further research. 
 
5.2 Research objectives and summary of research findings 
 
5.2.1 Research objective 1 
 
“To compare and contrast how R&D is accounted for in Ireland, the UK and the US 
and the impact of future convergence of global standard setters in this area.” 
 
Here the researcher found from the literature that the main accounting standards in 
these three countries relate to SSAP 13, IAS 38 and SFAS 2. These are quite similar 
standards, with the main contradiction in relation to the capitalization of R&D. From 
the findings of the questionnaires we can see the Irish listed companies must follow 
IAS 38, with only 40% meeting the criteria to capitalize development costs. The 
future of the convergence of the accounting standards process remains uncertain as to 
when or if this will go ahead. 
 
5.2.2 Research objective 2 
 
“To examine how the valuation of R&D is important.” 
 
The author found that the most commonly used method for valuing R&D was the cost 
method, with 90% using this method. The literature found that there were three main 
methods for the valuation of R&D; the market, the income and the cost method with 
only the market and the cost method being permitted under IAS 38. The valuation of 
R&D is important in relation to the capitalization of development costs, as some 
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research shows a positive effect on share price while others shows a negative effect. 
The findings of this research found that the capitalization of development costs had no 
effect on share price. 
 
5.2.3 Research objective 3 
 
“To establish what influence the R&D tax credit has on companies.” 
 
The author found that all respondents feel that the Irish R&D tax credit is an incentive 
for companies to engage in additional R&D, but not all the companies are eligible to 
receive the R&D tax credit. It is also clear from the literature that the R&D tax credit 
is important as most countries now have some form of R&D tax credits. One of the 
criticisms of the Irish R&D tax credit is that the base year approach is unfair so some 
countries and that a more volume based approach would be much preferred. 
 
5.2.4 Research objective 4 
 
“To determine what Ireland is like as an R&D economy.” 
 
The researcher concluded that although Ireland is regarded a good place to conduct 
R&D mainly due to its location, the tax regimes in place and the skills and 
qualifications of the workforce, the US is regarded as a superior place to conduct 
R&D mainly because of it access to R&D facilities. The author found that if Ireland is 
to increase in R&D activity certain improvements are required to be made. 
 
5.3 Conclusion 
 
At first the author believed that the accounting treatment for R&D was highly 
complex in Ireland, the UK and the US, this is why the researcher formed the research 
question: 
“How Research and Development is accounted for Ireland by companies listed on the 
Irish Stock Exchange (ISEX)?” 
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Therefore in order to answer this question the researcher broke this question into four 
main objectives, which can be seen above. The principal aim of the objectives was to 
answer the research question but also to expand the research further to include other 
factors which are important to R&D such as taxation, valuation and the Irish 
economy. The researcher will now, after completing Chapters 1 to 4, answer her 
research question. 
 
The complexity first thought by the researcher was not found after further 
investigation into the accounting treatment of R&D in Ireland, the UK and the US. 
The US clearly states that all R&D must be expensed to the statement of 
comprehensive income. In Ireland and the UK the main complexity for the accounting 
treatment refers to whether or not development expenditure meets the criteria, as 
research expenditure is expensed to the statement of comprehensive income unless as 
part of a business combination.  
 
All Irish listed companies must prepare their financial statements under IAS’s; 
therefore that exact accounting standard they must abide by is IAS 38, as has been 
discussed previously. This standard has a rigorous format that must be followed. 
However, the author wondered if this accounting standard could be manipulated like 
many standards before that have caused several corporate scandals. The majority of 
respondents answered “no” to the question of whether development expenditure could 
be manipulated to meet or not to meet the relevant criteria. However, the researcher 
feels that if this question was asked to such companies as Enron and WorldCom their 
answer would also have been no. Therefore, the author is reluctant to place any 
reliance on this piece of information. 
 
The valuation of all assets not just intangible assets has been questioned in the past, 
which is why the author felt that this objective would be relevant to this research. 
Valuation is an important aspect of accounting without it what would financial 
statements look like. As discussed in Chapter 2 all valuation methods have their 
advantages and disadvantages which makes them more suitable to certain types of 
items. IAS 38 states that the revaluation method, otherwise known the fair value 
model, and the cost model are applicable under this standard. Irish listed companies 
therefore must choose one of these methods but the main question is which one is 
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better? The results showed that most of the companies used the cost method. But are 
they correct? The author feels that although the cost method is preferred it has it 
flaws. However, as future income is most difficult to estimate, that perhaps that this is 
the correct valuation for R&D. 
 
Part of the literature for this dissertation found that there was a correlation between 
the capitalization of development expenditure and share price, whether it be positive 
or negative. If either way was found to be true, the author thinks that the disclosure of 
R&D would be significantly reduced. If the capitalization of development costs had a 
positive effect on share price more companies would be meeting the criteria, and vice 
versa - if it incurred a negative effect then some companies would not the criteria. 
However, this study found that there was no correlation between the capitalization of 
development expenditure and share price. On this point the researcher tends to agree 
with interviewee A when he said that the main effect on share price, apart from when 
there is an increase/decrease in profit or a publication, is what analysts have to say 
about financial statements. This is like the efficient market hypothesis (EMH) theory 
depending on how much the public knows will inadvertently depend on the value of 
share price.  
 
Financial reporting will always have some form discrepancy behind it. However 
accountancy as a whole focuses on many other aspects this is why the author included 
the R&D tax credit as one of the objectives. The R&D tax credit is widely used across 
the world. Ireland is said to have a good R&D tax credit (25%) and coupled with its 
low corporation tax rate (12.5%) makes it one of the most attractive locations for 
R&D. Ireland uses the base year approach in order to see what proportion of the R&D 
spend will qualify for the credit. This is not the same in all countries and this practice 
has been criticised both in the literature and in the findings. The results showed that a 
more volume based approach would be a good idea. The author agrees with these 
results and as R&D is believed to be of great importance for economic growth then all 
companies should be allowed reap the same benefits and not be penalised because of 
when it was formed.  
 
This objective leads the author to her final objective, if R&D is great for economic 
growth, then what is Ireland like as an R&D economy? Every country boasts about 
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what is great with their country and on this matter Ireland is no different. Ireland 
believes that due of its tax regimes, it is one of the better countries in which 
companies can conduct R&D here. The findings concluded that while the respondents 
felt that Ireland was a good location for R&D, other places such as the US were more 
advanced than Ireland. The researcher believes that although Ireland has great tax 
incentives for companies undertaking R&D, the economy is still underdeveloped for 
R&D. Currently there is a mismatch between the tax side of R&D and the economy 
side. Ireland needs to focus more on developing R&D facilities and increasing the 
education on R&D so that it can reach its full potential and attract more R&D 
companies. 
 
5.4 Recommendations 
 
5.4.1 Personal learning 
 
The author feels that she learned a lot from doing this research dissertation. The 
author’s analytical and critical skills have improved greatly as a direct response to 
carrying out this research. If the author were to carry out this research again there are 
a number of things that she would do differently. The main difference that the author 
would make is in choosing the subject matter. Although R&D is a very topical issue, 
finding sufficient literature that could be regarded as relevant was quite difficult. 
Therefore the author would have chosen an area on which literature is easily obtained. 
With regard to the study undertaken, the author would have carried out more 
interviews in order to have got more in-depth information from the questions asked. 
 
5.4.2 Suggestions for further research 
 
The author would suggest that more research be carried out on Irish organisations in 
order to gain a greater insight into this research topic. Future research should be more 
in-depth and have a larger sample. The author suggests that future research should 
include both listed and non-listed companies and face-to-face interviews with CFO’s 
where possible. Also, this study may be interesting in future years when the 
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convergence process has been completed to see what accounting treatment was 
chosen for R&D. 
 
5.5 Summary 
 
In summary, while the findings in this research are not absolute, it is hoped that the 
findings have added valuable insight to the people mentioned in 1.5 into how R&D is 
accounted for by Irish listed companies. The author believes that this dissertation has 
identified key issues that would boost R&D in Ireland, namely the R&D tax credit, 
valuation of R&D and finally the Irish economy as an R&D location. 
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Appendix 1 – Names of listed companies in Ireland 
 
 
1. Abbey PLC 
2. Aer Lingus Group PLC 
3. AGI Therapeutics PLC 
4. Allied Irish Banks PLC 
5. American International Group PLC  
6. Aminex PLC 
7. Aryzta AG 
8. Bank of Ireland PLC 
9. Blackrock International Land PLC 
10. Boundary Capital PLC 
11. CRH PLC 
12. C&C Group PLC 
13. Conroy Diamonds & Gold PLC 
14. CPL Resources PLC 
15. Datalex PLC 
16. DCC PLC 
17. Diageo PLC 
18. Donegal Creameries PLC 
19. Dragon Oil PLC 
20. Elan Corporation PLC 
21. FBD Holdings PLC 
22. First Derivatives PLC 
23. Fyffes PLC 
24. Gartmore Irish Growth Fund 
25. Glanbia PLC 
26. Grafton Group PLC 
27. Greencore Group PLC 
28. ICON PLC 
29. IFG Group PLC 
30. Independent News and Media PLC 
31. Irish Continental Group PLC 
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32. Irish Life & Permanent Group Holdings PLC 
33. ISEQ Exchange Traded Fund PLC 
34. Karelian Diamond 
35. Kenmare Resources PLC 
36. Kerry Group PLC 
37. Kingspan Group PLC 
38. McInerney Holdings PLC 
39. Merrion Pharmaceuticals PLC 
40. Mosney PLC 
41. Norkom Group PLC 
42. Oglesby & Butler PLC 
43. Origin Enterprises PLC 
44. Ormonde Mining PLC 
45. Ovoca Gold PLC 
46. Petroceltic International PLC 
47. Petroneft Resources PLC 
48. Prime Active Capital PLC 
49.  Providence Resources PLC 
50. Readymix PLC 
51. Real Estate Opportunities PLC 
52. Ryanair Holdings PLC 
53. Siteserv PLC 
54. Smurfit Kappa Group PLC 
55. Tesco PLC 
56. Total Produce PLC 
57. Tullow Oil PLC 
58. TVC Holdings PLC 
59. United Drug PLC 
60. UTV Media PLC 
61. Waterford Wedgewood PLC 
62. Worldspreads Group PLC 
63. Zamano PLC 
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Appendix 2 – Cover letter for questionnaires 
 
Dear Chief Financial Officer (CFO), 
 
My name is Ann Marie Mc Ginty. I am doing a Master of Arts in Accounting in 
Letterkenny Institute of Technology (LYIT). I am currently carrying out research on 
the accounting treatment of research and development (R&D), in particular by 
companies quoted on the Irish stock exchange, as part of my dissertation.  
 
As part of my research I am conducting a survey on R&D, and would be grateful if 
you would be willing to participate in this research. Participation in this research will 
involve the completion of the questionnaire enclosed. The questionnaire should take 
no more than 10 minutes to complete. Also, for your convenience I have enclosed a 
stamped-addressed envelope for returning the questionnaire.  
 
The survey should be completed by the CFO or the individual who is in charge of the 
preparation of financial statements, where possible. All information gathered as part 
of this research will be kept completely confidential, and no individual companies or 
persons will be named. 
 
It would be very helpful if this questionnaire could be completed as quickly as 
possible. If you have any questions about the questionnaire or my research please do 
not hesitate to contact me at L00057998@lyit.ie, or alternatively you can phone me 
on 086-0663995. 
 
Thank you for your co-operation. Your input is greatly appreciated. 
 
Yours sincerely, 
Ann Marie Mc Ginty 
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Appendix 3 – Questionnaire 
 
For the purposes of this questionnaire, elements of R&D are defined as: 
           
Basic Research: Experimental or theoretical work undertaken primarily to 
acquire new knowledge, without any particular application 
or use in view.  
Applied Research: Original investigation undertaken in order to acquire new 
knowledge, primarily directed towards a specific practical 
aim or objective. 
Development: Systematic work, drawing on existing knowledge gained 
from research and practical experience that is directed to 
producing new materials, products and devices, to installing 
new processes, systems and services, or to improving 
substantially those already produced or installed. 
1. General Information 
      
1.1 What position do you hold within the company? 
      
 Managing Director      
      
 Accountant / Financial Manager     
      
 General Manager      
      
 Other (Please specify)       
      
      
1.2 What sector does your company operate in? 
      
 Pharmaceuticals      
      
 Food      
      
 Construction      
      
 Technology      
      
 Financing      
      
 Other (Please specify)       
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1.3 Do you think intangible assets should be shown on the Statement of 
Financial Position? 
      
 Yes      
      
 No       
      
      
1.4 Do you undertake Research & Development (R&D)? 
      
 Yes      
      
 No (Please go to Section 5)     
      
      
2. Accounting for R&D 
      
2.1 If you undertake R&D which of the following is applicable to your 
company? 
      
 Basic Research      
      
 Applied Research      
      
 Development only      
      
 Research & Development      
      
      
2.2 How many employees are involved in R&D? 
      
 < 10      
      
 < 20      
      
 20 +      
      
      
2.3 On average how much does your company spend on R&D per 
annum? 
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2.4 What percentage of overall cost does this amount to? 
      
 Less than 10%      
      
 Between 10% and 25%      
      
 Between 26% and 50%      
      
 Over 50%      
      
      
2.5 Do you find it difficult to separate the expenditure incurred on 
research from development? 
      
 Yes      
      
 No       
      
      
2.6 If yes what are the difficulties? 
      
 The two are too closely linked     
      
 Unsure of which components are research & which are 
development 
    
      
 Other (Please specify)       
      
      
2.7 International Accounting Standards does not allow for the 
capitalization of Research expenditure, but does your company  
 capitalize development expenditure? 
      
 Yes      
      
 No       
      
      
2.8 If you do not capitalize development, is it because you do not meet the 
criteria to capitalize it? 
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2.9 Do you feel that the accounting standard is easy to manipulate to 
allow you to treat development in the way you prefer? 
      
 Yes      
      
 No       
      
 Please provide an explanation below    
           
           
           
      
      
2.10 Where is the R&D performed? 
      
 In house only      
      
 Contracted Out only      
      
 Both in house and contracted (please specify      
 percentage for in house)                                      
      
      
2.11 Where was the R&D performed? 
      
 Within Ireland only      
      
 Outside Ireland only      
      
 Both within and outside Ireland (please specify      
 percentage for in Ireland)                                      
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2.12 Does your company have a dual stock market listing? 
      
 Yes      
      
 No       
      
 If yes are there any problems with accounting for R&D between 
these countries? 
  
           
           
           
      
      
2.13 Did your company engage in any joint R&D projects with any of the 
following parties? 
      
a. Other firms in Ireland 
      
 Yes      
      
 No       
      
b. Other firms outside Ireland 
      
 Yes      
      
 No       
      
      
3. Irish Tax Credit 
      
3.1 Do you avail of the Irish R&D Tax Credit? 
      
 Yes      
      
 No      
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3.2 Do you think this credit is valuable to companies?    
      
 Yes      
      
 No      
      
 Please provide explanation below    
           
           
           
      
      
3.3 Do you think the tax credit is an incentive for companies to engage in 
additional R&D? 
      
 Yes      
      
 No      
      
 Please provide explanation below    
           
           
           
      
      
3.4 If you do not avail of the tax credit, why not?    
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3.5 Do you think that Ireland’s base year approach is a good idea or 
should it be more volume based like other countries? 
 
      
 Yes (Good Idea)      
      
 No (Should be volume based)     
      
 Please provide explanation below    
           
           
           
      
      
4. Valuation of R&D 
      
4.1 How do you value the R&D undertaken? 
      
 Cost      
      
 Fair Value (FV)      
      
 N/A      
      
 Other (Please specify)      
      
      
4.2 If valuation is based on FV, how is this determined?    
           
           
           
      
      
4.3 Do you believe that capitalization of development has: 
      
 A positive effect on share price     
      
 A negative effect on share price     
      
 No effect on share price      
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5. Ireland as an R&D Economy 
      
5.1 In your opinion do you believe Ireland is a good place to conduct 
R&D? 
      
 Yes       
      
 No       
      
 Please provide explanation below    
           
           
           
      
      
5.2 What are the impediments of carrying out R&D in Ireland? 
           
           
           
      
      
5.3 What other locations do you feel are more favourable than Ireland, 
and why? 
           
           
           
      
      
5.4 What improvements could be made to make Ireland more R&D 
friendly? 
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5.5 Do you think the current recession has had a positive or negative 
effect on companies conducting R&D? 
      
 Positive      
      
 Negative      
      
      
6. Other 
      
6.1 Feel free to make any additional comments on this matter. 
           
           
           
      
      
 Thank you for your co-operation.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDICES 
 76 
Appendix 4 – Theme sheet for interviews 
 
Do you think intangible assets should be shown on the balance sheet? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Do many of your clients undertake research and development? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
International Accounting Standards does not allow for the capitalization of 
research expenditure, but should it allow the capitalization of development 
expenditure where the criteria is met? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Do you feel that some companies manipulate whether or not they met the criteria 
of capitalization? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Do you think the R&D tax credit is valuable to companies? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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Do you think this credit is an incentive for companies to engage in additional 
R&D? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Do you think that Ireland’s base year approach is a good idea or should it be 
more volume based like other countries? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
How should R&D be valued, e.g. cost, fair value? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Do you think capitalization has any effect on share price? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Is Ireland a good place to conduct R&D and why? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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What are the problems (if any) is there of carrying out R&D in Ireland? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
What other locations would be more favourable than Ireland to conduct R&D? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
What improvements could be made to make Ireland more R&D friendly? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Do you think the current recession has any effect on companies conducting 
R&D, i.e. would they do more or less R&D work? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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Appendix 5 - Results of the questionnaires  
 
Question 1.1 – What position do you hold in within the company? 
 
0
18
0
2
0 5 10 15 20
Managing Director
Accountant/ Financial Manager
General Manager
Other
No. of Respondents
 
 
 
 
 
 
Question 1.2 – What sector does your company operate in? 
 
11
0
3
2
2
2
0 2 4 6 8 10 12
Other
Financing
Technology
Construction
Food
Pharmaceuticals
No. of Respondents
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Question 1.3 – Do you think intangible assets should be shown on the 
Statement of Financial Position? 
 
3
16
0 5 10 15 20
No
Yes
No. of Respondents
 
 
 
 
 
 
Question 1.4 – Do you undertake Research and Development (R&D)? 
 
9
11
0 2 4 6 8 10 12
No
Yes
No. of Respondents
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Question 2.1 – If you undertake R&D which of the following is applicable to your 
company? 
 
9
2
0
0
0 2 4 6 8 10
Research &
Development
Development
only
Applied
Research
Basic Research
No. of Respondents
 
 
 
 
 
 
Question 2.2 – How many employees are involved in R&D? 
 
7
2
2
0 2 4 6 8
20+
Between 10 and
19
Less than 10
No. of Respondents
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Question 2.3 – On average how much does your company spend on R&D 
per annum? 
 
1.5 0.4
4.75
1 0.25
6 5
25
0
5
10
15
20
25
30
R
&
D
 s
p
en
d
 i
n
 m
il
li
o
n
s 
(€
)
 
 
 
 
 
 
Question 2.4 – What percentage of overall cost does this amount to? 
 
1
3
1
5
0 1 2 3 4 5 6
Over 50%
Between 26%
and 50%
Between 10%
and 25%
Less than 10%
No. of Respondents
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Question 2.5 – Do you find it difficult to separate the expenditure incurred 
on research from development? 
 
6
4
0 1 2 3 4 5 6 7
No
Yes
No. of Respondents
 
 
 
 
 
 
Question 2.6 – If yes, what are the difficulties? 
 
0
0
4
0 1 2 3 4 5
Other
Unsure of which components are
research & which are development
The two are too closely linked
No. of Respondents
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Question 2.7 – International Accounting Standards does not allow for the 
capitalization of Research expenditure, but does your company capitalize 
development expenditure? 
 
6
4
0 1 2 3 4 5 6 7
No
Yes
No. of Respondents
 
 
 
 
 
 
Question 2.8 – If you do not capitalize development, is it because you do 
not meet the criteria to capitalize it? 
 
1
5
0 1 2 3 4 5 6
No
Yes
No. of Respondents
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Question 2.9 – Do you feel that the accounting standard is easy to 
manipulate to allow you to treat development in the way you prefer? 
 
8
1
0 2 4 6 8 10
No
Yes
No. of Respondents
 
 
 
 
 
 
Question 2.10 – Where is the R&D performed? 
 
2
1
7
0 2 4 6 8
Both in house &
contracted out
Contracted out
only
In house only
No. of Respondents
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Question 2.11 – Where was the R&D performed? 
 
5
1
4
0 1 2 3 4 5 6
Both within &
outside Ireland
Outside Ireland
only
Within Ireland
only
No. of Respondents
 
 
 
 
 
 
Question 2.12 – Does your company have a dual stock market listing?  
 
4
6
0 1 2 3 4 5 6 7
No
Yes
No. of Respondents
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Question 2.13 – Did your company engage in any joint R&D projects with 
any of the following parties? 
 
0 2 4 6 8 10
In Ireland
Outside Ireland
No
Yes 
 
 
 
 
 
 
Question 3.1 – Do you avail of the Irish R&D tax credit? 
 
4
6
0 1 2 3 4 5 6 7
No
Yes
No. of Respondents
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Question 3.2 – Do you think this credit is valuable to companies? 
 
1
8
0 2 4 6 8 10
No
Yes
No. of Respondents
 
 
 
 
 
 
Question 3.3 – Do you think the tax credit is an incentive for companies to 
engage in additional R&D? 
 
0
9
0 2 4 6 8 10
No
Yes
No. of Respondents
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Question 3.4 – If you do not avail of the tax credit, why not? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Question 3.5 – Do you think that Ireland’s base year approach is a good 
idea or should it be more volume based like other countries? 
 
7
3
0 2 4 6 8
No (Should be
volume based)
Yes (Good Idea)
No. of Respondents
 
 
 
 
Question 4.1 – How do you value the R&D undertaken? 
 
0
0
1
9
0 2 4 6 8 10
Other
N/A
Fair Value
Cost
No. of Respondents
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Question 4.2 – If valuation is based on fair value, how is this determined? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________  
 
Question 4.3 – Do you believe that capitalization of development has: 
 
8
0
1
0 2 4 6 8 10
No effect on
share price
A negative effect
on share price
A positive effect
on share price
No. of Respondents
 
 
 
 
 
Question 5.1 – In your opinion do you believe Ireland is a good place to 
conduct R&D? 
1
15
0 5 10 15 20
No
Yes
No. of Respondents
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Question 5.2 – What are the impediments of carrying out R&D in Ireland? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Question 5.3 – What other locations do you feel are more favourable than 
Ireland, and why? 
 
2
6
3
2
1
1
1
0 1 2 3 4 5 6 7
Eastern Europe
US
India
China
Israel
Luxembourg
Netherlands
No. of Respondents
 
 
 
Question 5.4 – What improvements could be made to make Ireland more 
R&D friendly? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Question 5.2 – What are the impediments of carrying out R&D in Ireland? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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Question 5.5 – Do you think the current recession has had a positive effect 
on companies conducting R&D? 
 
12
7
0 2 4 6 8 10 12 14
Negative effect
Positive effect
No. of Respondents
 
 
